ICU Medical (ICUI) Stock Highlights

156.46 | -0.27%

2024-12-27 02:26:49

ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. After ICUs acquisition of Hospira Infusion Systems from Pfizer in 2017, it became one of the largest players in this concentrated industry, holding top-tier positions in its major reporting segments: infusion consumables (37% of 2020 revenue), IV solutions (31%), infusion systems (28%), and critical care (4%). The combined entity remains primarily U.S. focused, generating over 70% of its sales domestically.

Statistics

Range Today

155.64 157.24

Volume Today 142.69K

Range 1 Year

86.8 196.26

Volume 1 Year 67.91M

Range 3 Year

78.28 251.73

Volume 3 Year 176.2M

Range 10 Year

78.28 321.7

Volume 10 Year 447.68M

Highlights

Market Capitalization 4.36B (mid)

Floating Shares 22.5M

Current Price 156.46

Price To Earnings -61.84

Price To Revenue 2.46

Price To Book 2.12

Earnings Per Share -2.9

Payout Ratio 0%

Performance

Latest -0.27%

1 Month -7.13%

3 Months -11.47%

6 Months +36.23%

1 Year +58.94%

3 Years -33.61%

5 Years -16.9%

10 Years +86.57%

Benchmarks

Market Capitalization

20 / 44

Gross Profits

15 / 40

Total Revenue

14 / 43

Total Rank

12 / 44

Free Cashflow

18 / 44

Performance 5 years

21 / 44

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.